GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Binex Co Ltd (XKRX:053030) » Definitions » Gross Profit

Binex Co (XKRX:053030) Gross Profit : ₩36,164 Mil (TTM As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Binex Co Gross Profit?

Binex Co's gross profit for the three months ended in Mar. 2024 was ₩2,460 Mil. Binex Co's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was ₩36,164 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Binex Co's gross profit for the three months ended in Mar. 2024 was ₩2,460 Mil. Binex Co's Revenue for the three months ended in Mar. 2024 was ₩29,710 Mil. Therefore, Binex Co's Gross Margin % for the quarter that ended in Mar. 2024 was 8.28%.

Binex Co had a gross margin of 8.28% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

During the past 13 years, the highest Gross Margin % of Binex Co was 47.40%. The lowest was 26.53%. And the median was 44.82%.

Warning Sign:

Binex Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.5%.


Binex Co Gross Profit Historical Data

The historical data trend for Binex Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binex Co Gross Profit Chart

Binex Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56,768.01 63,027.89 59,985.21 70,502.91 56,947.80

Binex Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,244.15 15,007.15 8,876.04 9,820.46 2,460.09

Competitive Comparison of Binex Co's Gross Profit

For the Biotechnology subindustry, Binex Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Binex Co's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Binex Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Binex Co's Gross Profit falls into.



Binex Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Binex Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=154824.776 - 97876.973
=56,948

Binex Co's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=29710.078 - 27249.986
=2,460

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩36,164 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Binex Co's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=2,460 / 29710.078
=8.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Binex Co  (XKRX:053030) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Binex Co had a gross margin of 8.28% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Binex Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Binex Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Binex Co (XKRX:053030) Business Description

Traded in Other Exchanges
N/A
Address
480-2 Janglim-dong, Saha-gu, Busan, KOR, 604-846
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.

Binex Co (XKRX:053030) Headlines

No Headlines